Dinova Capital is an international private equity investment institution focusing on the medical and health industry.

DiNovA Capital's management team boasts extensive experience in entrepreneurship, investment, and management within the healthcare industry. Committed to a truly international approach, ours investments span across the United States, Israel, Europe, and China. Leveraging its experienced investment team, collaborates closely with global industry experts and major healthcare institutions to focus on venture capital and private equity investments in entrepreneurial and growth-stage companies.

DiNovA Capital's unique business model facilitates the integration of world-class medical technologies into China, enhancing and expanding products, significantly reducing production costs, and rapidly delivering advanced technologies to the global market. This approach not only brings substantial returns to investors but also ensures that cutting-edge innovations benefit the world in a short timeframe.

In 2015, DiNovA Capital was honored with the "Top 5 Best Investment Cases in China's Healthcare Industry" award by China Venture Capital Group and was named among the "Top 30 Best Foreign Venture Capital Institutions."